CalBio Draws US Stock Exchange

15 September 1996

The New York-based American Stock Exchange has decided to establish a presence in Southern California where many of the country's biotechnology companies are located.

"We think California is as important as any country, particularly in terms of growth," declared Tom Ryan, president and chief operating officer of the American Stock Exchange. "The concentration of successful health care technology companies in Southern California is remarkable in itself. The fact that they're just now coming to market with their stock offerings, as well as their products, creates stunning financial opportunities. The American Stock Exchange wants to be close by to service their financial needs. Our West Coast office opened in Los Angeles this summer," he said.

Mr Ryan will be speaking at the CalBioSummit '96 conference at the San Diego Convention Center in October.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight